SEC Filing Summary: Spherix Incorporated (Form 8-K)
Business Context and Reporting Period
This Form 8-K was filed by Spherix Incorporated on January 10, 2011. The report serves as a current disclosure pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934. The registrant is incorporated in Delaware and maintains its principal executive offices in Bethesda, Maryland.
Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. This document is a regulatory disclosure regarding an upcoming event rather than a financial statement.
Material Changes
No material changes to financial performance or operations are reported in this filing. The document focuses solely on the scheduling of an investor presentation.
Guidance, Outlook, and Management Commentary
On January 11, 2011, Dr. Robert A. Lodder (President) and Ms. Leisa Dennehy (Commercial and Corporate Development Advisor) are scheduled to deliver a company presentation to prospective investors. The event will take place at the OneMedForum SF 2011 and Biotech Showcase 2011 in San Francisco, CA. The presentation materials are attached as Exhibit 99.1 and are available on the company's website.
Key Facts for Investor Verification
- Verify the content of the investor presentation attached as Exhibit 99.1 for updated business strategy or financial outlook.
- Confirm the company's current cash position and runway, as this 8-K does not disclose financial status.
- Monitor the company's website (www.spherix.com) for the referenced presentation materials.
- Note that the filing is signed by Robert L. Clayton, CFO, on behalf of the registrant.